Company intelligence / Profile preview

Genlantis

San Diego, California, United Statesgenlantis.com ↗

Ownership: Private
Development stage: Other

Overview

Genlantis was a biotechnology tools provider specializing in transfection technologies and cell culture products for life science research. It did not have clinical programs but supplied key reagents used in gene delivery and protein expression studies. The brand/product line continues under AMSBIO after acquisition.

Modalities: Reagents for transfectionProtein delivery reagents
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Genlantis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genlantis.

Explore the full profile